Cadila gets USFDA Approval for Generic Drug to Treat Parkinson’s Disease
Cadila Healthcare announced on December 14, 2017, that they have received approval from the US Food and Drug Administration (FDA) to manufacture Pramipexole Dihydrochloride extended-release tablets, which is used for treatment of Parkinson’s disease.
Parkinson’s disease is a neurodegenerative disorder, which results in to progressive deterioration of motor function due to loss of dopamine-producing brain cells. It is characterized by symptoms such as dementia, depression, and anxiety. According to Parkinson’s Disease Therapeutic Market report published by Coherent Market Insights, there is no proper cure available for the treatment of Parkinson’s disease currently. Treatments options such as medication and surgery to manage the symptoms are available. However, various formulations of drugs such as Pramipexole Dihydrochloride can be effectively used to treat and lower the symptoms of disease.
Zydus Pharmaceuticals (USA) Inc, Cadila Healthcare’s has now received the FDA approval for Pramipexole Dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the American pharmaceutical market.
Pramipexole Dihydrochloride extended-release tablets is available in strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg. The group also received the final approval from the USFDA to market Nitrofurantoin Capsules USP (macrocrystals), 50 mg and 100 mg, which is indicated to treat acute uncomplicated urinary tract infections. Both the drugs will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. Shares of Cadila on December 15, 2017 ended 0.34 per cent up at Rs 409.35 on BSE.
Request Sample copy of Parkinson’s Disease Therapeutic Market Report @ https://www.coherentmarketinsights.com/insight/request-sample/494
You may be interested
Cutting Equipment Market-Outlook, Insights and Revenue OpportunitiesAlex Mathew - March 24, 2018
In terms of volume, the global cutting equipment market was pegged at over 3,400 thousand units in 2016 and is projected to reach 4,900 thousand units by…
Cloud Backup Market Projections and Future OpportunitiesAlex Mathew - March 24, 2018
Cloud backup also known as online backup or remote backup is an alternative to conventional backup. Cloud backup aids in creating, editing, managing, and restoring data backup.…
Growing Incidence of Phishing Attacks Across the Globe Fueling Growth of Ransomware Protection MarketAlex Mathew - March 24, 2018
Ransomware protection refers to security against malicious cryptovirology software that prevents users from accessing their data or threaten to make their private information public unless a ransom…